Main Content

Press Release

Invitation: Elekta's Interim Report May-January 2009/10

Stockholm

2010-03-03

Elekta's Interim Report May-January 2009/10


Elekta’s interim report for the first nine months 2009/10 will be published on March 10 with the following schedule:

  • The report will be published on March 10 at around 07.30 CET.
  • Elekta will host a telephone conference 10.15-11.15 CET on March 10 with CEO Tomas Puusepp and CFO Håkan Bergström.

To take part in the conference call, please dial in about ten minutes in advance.

  • Swedish dial-in number: +46 (0)8 5052 0114
  • UK dial-in number: +44 (0)207 1620 177
  • US dial-in number: + 1 334 323 6203


The telephone conference will be broadcasted over the Internet (audio only). Please visit http://www.elekta.com/corporate_international_investor_events.php

A replay of the telephone conference will be available until March 17. Please dial Sweden: +46 (0)8 5052 0333, UK: +44 (0)20 7031 4064, US: +1 954 334 0342, and use access code 859345.

Best regards,

Stina Thorman
Investor Relations

This information was brought to you by Cision http://www.cisionwire.com
http://www.cisionwire.com/elekta/invitation--elekta-s-interim-report-may-january-2009-10

The following files are available for download:


Invitation

 

###

For further information, please contact:

Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37, email: stina.thorman@elekta.com
 Time zone: CET: Central European

Michelle Lee, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.lee@elekta.com
 Time zone: EDT: Eastern Daylight Time

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb.

Visit Elekta - www.elekta.com